JP2022527144A5 - - Google Patents

Info

Publication number
JP2022527144A5
JP2022527144A5 JP2021540477A JP2021540477A JP2022527144A5 JP 2022527144 A5 JP2022527144 A5 JP 2022527144A5 JP 2021540477 A JP2021540477 A JP 2021540477A JP 2021540477 A JP2021540477 A JP 2021540477A JP 2022527144 A5 JP2022527144 A5 JP 2022527144A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
car according
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021540477A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022527144A (ja
Filing date
Publication date
Priority claimed from PCT/US2019/019566 external-priority patent/WO2019165421A1/en
Priority claimed from PCT/US2019/021556 external-priority patent/WO2019173815A2/en
Application filed filed Critical
Priority claimed from PCT/US2020/013410 external-priority patent/WO2020146902A2/en
Publication of JP2022527144A publication Critical patent/JP2022527144A/ja
Publication of JP2022527144A5 publication Critical patent/JP2022527144A5/ja
Priority to JP2025126649A priority Critical patent/JP2025172739A/ja
Pending legal-status Critical Current

Links

JP2021540477A 2019-01-11 2020-01-13 抗可変muc1*抗体およびその使用 Pending JP2022527144A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025126649A JP2025172739A (ja) 2019-01-11 2025-07-29 抗可変muc1*抗体およびその使用

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962791661P 2019-01-11 2019-01-11
US62/791,661 2019-01-11
PCT/US2019/019566 WO2019165421A1 (en) 2018-02-26 2019-02-26 Diagnostic methods using anti-muc1* antibodies
USPCT/US2019/019566 2019-02-26
USPCT/US2019/021556 2019-03-11
PCT/US2019/021556 WO2019173815A2 (en) 2018-03-09 2019-03-11 Method for anti-muc1* car t cell stimulation
PCT/US2020/013410 WO2020146902A2 (en) 2019-01-11 2020-01-13 Anti-variable muc1* antibodies and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025126649A Division JP2025172739A (ja) 2019-01-11 2025-07-29 抗可変muc1*抗体およびその使用

Publications (2)

Publication Number Publication Date
JP2022527144A JP2022527144A (ja) 2022-05-31
JP2022527144A5 true JP2022527144A5 (cg-RX-API-DMAC7.html) 2023-04-18

Family

ID=71521210

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021540477A Pending JP2022527144A (ja) 2019-01-11 2020-01-13 抗可変muc1*抗体およびその使用
JP2025126649A Pending JP2025172739A (ja) 2019-01-11 2025-07-29 抗可変muc1*抗体およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025126649A Pending JP2025172739A (ja) 2019-01-11 2025-07-29 抗可変muc1*抗体およびその使用

Country Status (8)

Country Link
US (1) US12583927B2 (cg-RX-API-DMAC7.html)
EP (1) EP3908603A4 (cg-RX-API-DMAC7.html)
JP (2) JP2022527144A (cg-RX-API-DMAC7.html)
CN (2) CN120484122A (cg-RX-API-DMAC7.html)
AU (1) AU2020205735A1 (cg-RX-API-DMAC7.html)
CA (1) CA3126391A1 (cg-RX-API-DMAC7.html)
IL (1) IL284772A (cg-RX-API-DMAC7.html)
WO (1) WO2020146902A2 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3256494A4 (en) 2015-02-10 2018-12-05 Minerva Biotechnologies Corporation Humanized anti-muc1* antibodies
WO2019165421A1 (en) * 2018-02-26 2019-08-29 Minerva Biotechnologies Corporation Diagnostic methods using anti-muc1* antibodies
WO2020146902A2 (en) 2019-01-11 2020-07-16 Minerva Biotechnologies Corporation Anti-variable muc1* antibodies and uses thereof
CA3183682A1 (en) 2020-06-26 2021-12-30 Minerva Biotechnologies Corporation Anti-nme antibody and method of treating cancer or cancer metastasis
CN116234828A (zh) * 2020-07-29 2023-06-06 米纳瓦生物技术公司 抗可变muc1*抗体及其用途
EP4210733B1 (en) * 2020-09-04 2024-11-06 Miltenyi Biotec B.V. & Co. KG System for inducible expression of an adapter in immune cells
IL312606A (en) * 2021-11-09 2024-07-01 Janssen Biotech Inc Microfluidic co-encapsulation device and system and methods for identifying t-cell receptor ligands
WO2023123195A1 (zh) * 2021-12-30 2023-07-06 深圳市先康达生命科学有限公司 一种目的基因可调控的工程化免疫细胞及其制备方法和应用
CA3248038A1 (en) * 2022-04-12 2023-10-19 Minerva Biotechnologies Corporation ANTI-MUC1* VARIABLE ANTIBODIES AND RELATED USES
IL316918A (en) * 2022-05-09 2025-01-01 Minerva Biotechnologies Corp Chimeric antigen receptor and IL-18 receptor compositions and methods of using them
US20240261406A1 (en) 2023-02-02 2024-08-08 Minerva Biotechnologies Corporation Chimeric antigen receptor compositions and methods for treating muc1* diseases
EP4587063A1 (en) * 2023-10-11 2025-07-23 Minerva Biotechnologies Corporation Anti-muc1* antibody drug complexes and uses thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240390418A1 (en) 1997-09-04 2024-11-28 Minerva Biotechnologies Corporation Anti-variable muc1* antibodies and uses thereof
EP1290217A2 (en) * 2000-02-04 2003-03-12 Aeomica, Inc. Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence
AU2002368077B2 (en) 2001-07-12 2010-03-04 Jefferson Foote Super humanized antibodies
GB0802931D0 (en) * 2008-02-18 2008-03-26 Queen Mary & Westfield College Synthetic scFv analogue to the 6313/G2 (anti angiotensin II type 1 receptor) monoclonal anitbody variable regions
JP2012504961A (ja) 2008-10-06 2012-03-01 ミネルバ バイオテクノロジーズ コーポレーション Muc1*抗体
JP2012034668A (ja) * 2010-08-12 2012-02-23 Tohoku Univ ヒト型化抗egfr抗体リジン置換可変領域断片及びその利用
AU2013302620B2 (en) * 2012-08-14 2018-08-02 Minerva Biotechnologies Corporation Stem cell enhancing therapeutics
CN106132992B (zh) 2014-01-29 2020-08-07 达娜-法勃肿瘤研究所公司 针对muc1-c/胞外结构域(muc1-c/ecd)的抗体
EP4050103A1 (en) 2014-04-07 2022-08-31 Minerva Biotechnologies Corporation Anti-nme antibody
EP3256494A4 (en) * 2015-02-10 2018-12-05 Minerva Biotechnologies Corporation Humanized anti-muc1* antibodies
AU2016229189A1 (en) * 2015-03-06 2017-09-21 Sorrento Therapeutics, Inc. Antibody therapeutics that bind TIM3
CA3039797A1 (en) * 2016-10-11 2018-04-19 Minerva Biotechnologies Corporation Humanized anti-muc1* antibodies and use of cleavage enzyme
US11578115B2 (en) * 2017-01-10 2023-02-14 The General Hospital Corporation Chimeric antigen receptors based on alternative signal 1 domains
WO2019104306A1 (en) 2017-11-27 2019-05-31 Minerva Biotechnologies Corporation Humanized anti-muc1* antibodies and direct use of cleavage enzyme
MX428412B (es) 2017-12-24 2025-11-13 Noile Immune Biotech Inc Celula inmunocompetente que expresa una molecula de superficie celular que reconoce especificamente la mesotelina humana, il-7 y ccl19
IL326873A (en) 2017-12-29 2026-04-01 Memorial Sloan Kettering Cancer Center Enhanced chimeric antigen receptors and uses thereof
WO2019165421A1 (en) * 2018-02-26 2019-08-29 Minerva Biotechnologies Corporation Diagnostic methods using anti-muc1* antibodies
EP3868783A4 (en) 2018-10-19 2022-01-19 Cartexell Inc. ANTI-L1CAM ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND CHIMERIC ANTIGEN RECEPTOR THEREOF
WO2020116686A1 (ko) 2018-12-06 2020-06-11 고려대학교 산학협력단 인간 항-antxr 키메라 항원 수용체 및 이의 용도
WO2020146902A2 (en) 2019-01-11 2020-07-16 Minerva Biotechnologies Corporation Anti-variable muc1* antibodies and uses thereof
CN110903401A (zh) 2019-11-20 2020-03-24 浙江大学 一种靶向cd19的二代嵌合抗原受体及其表达载体与应用
CN116234828A (zh) 2020-07-29 2023-06-06 米纳瓦生物技术公司 抗可变muc1*抗体及其用途
US20240261406A1 (en) 2023-02-02 2024-08-08 Minerva Biotechnologies Corporation Chimeric antigen receptor compositions and methods for treating muc1* diseases

Similar Documents

Publication Publication Date Title
JP2021094037A5 (cg-RX-API-DMAC7.html)
JP2023537326A5 (cg-RX-API-DMAC7.html)
JP2019527557A5 (cg-RX-API-DMAC7.html)
JP2025065142A5 (cg-RX-API-DMAC7.html)
JP2023123502A5 (cg-RX-API-DMAC7.html)
FI3334765T3 (fi) Yksidomeenivasta-aineisiin perustuvia kimeerisiä antigeenireseptoreita ja menetelmiä niiden käyttämiseksi
JP2023534808A5 (cg-RX-API-DMAC7.html)
JP2023059873A5 (cg-RX-API-DMAC7.html)
JP2020533958A5 (cg-RX-API-DMAC7.html)
JP2025186319A5 (cg-RX-API-DMAC7.html)
JP2021500881A5 (cg-RX-API-DMAC7.html)
JP2020114264A5 (cg-RX-API-DMAC7.html)
US20190023764A1 (en) Car having replicated binding motifs in a co-stimulatory domain
JP2020513754A5 (cg-RX-API-DMAC7.html)
JP2024023228A5 (cg-RX-API-DMAC7.html)
JP2017519502A5 (cg-RX-API-DMAC7.html)
KR20190065318A (ko) 세포에 의해 발현되는 생물학적 활성을 조절하는 결합 분자
JP2020525536A5 (cg-RX-API-DMAC7.html)
JP2017522893A5 (cg-RX-API-DMAC7.html)
RU2018109426A (ru) Химерные антигенные рецепторы со встроенными контролируемыми функциями
JP2020513829A5 (cg-RX-API-DMAC7.html)
JP2023544890A5 (cg-RX-API-DMAC7.html)
JP2022514693A5 (cg-RX-API-DMAC7.html)
JP2017522882A5 (cg-RX-API-DMAC7.html)
JP2021513857A5 (cg-RX-API-DMAC7.html)